|
 |
LeucovorinThis page contains recent news articles, when available, and an overview of Leucovorin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Leucovorin (when available) Leucovorin is one of several active, chemically reduced derivatives of folic acid. It is useful as an antidote to drugs which act as folic acid antagonists. Leucovorin is a mixture of the diastereoisomers of the 5-formyl derivative of tetrahydrofolic acid (THF). The biologically active compound of the mixture is the (-)-l-isomer, known as Citrovorum factor or (-)-folinic acid. Leucovorin does not require reduction by the enzyme dihydrofolate reductase in order to participate in reactions utilizing folates as a source of “one-carbon” moieties. Administration of leucovorin can counteract the therapeutic and toxic effects of folic acid antagonists such as methotrexate, which act by inhibiting dihydrofolate reductase. Leucovorin has also been used to enhance the activity of fluorouracil. Used to treat osteosarcoma (after high dose methotrexate therapy), to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosages of folic acid antagonists, and to treat megaloblastic anemias due to folic acid deficiency. Also used in combination with 5-fluorouracil to prolong survival in the palliative treatment of patients with advanced colorectal cancer. Mechanism Of Action: As leucovorin is a derivative of folic acid, it can be used to increase levels of folic acid under conditions favoring folic acid inhibition (following treatment of folic acid antagonists such as methotrexate). Leucovorin enhances the activity of fluorouracil by stabilizing the bond of the active metabolite (5-FdUMP) to the enzyme thymidylate synthetase. News Articles on Leucovorin Genotype Can Figure in Cancer Prognosis and Treatment Studies explore role of ... - Jan 4, 2010 Italy, and colleagues enrolled 59 patients with colorectal cancer treated with irinotecan plus fluorouracil/leucovorin (FOLFIRI) with either the *1/*1 ... ModernMedicine Xeloda® in Combination with Oxaliplatin Filed in Europe for the Adjuvant ... - Jan 4, 2010 ...after surgery lived disease-free for longer compared to those treated with commonly used chemotherapy regimen 5-fluorouracil/leucovorin (5-FU/LV). ... Pharmaceutical Processing Toxicity risk of non-target organs at risk receiving low-dose radiation: case ... - Dec 31, 2009 Two weeks after the radiotherapy had been completed, the first course of chemotherapy comprising gemcitabine, fluorouracil, and leucovorin was administered. ... 7thSpace Interactive (press release) Aspirin Wards Off Colorectal Cancer Death - Dec 14, 2009 Dr Grothey recounted that for decades, the standard first-line therapy consisted of the drugs fluorouracil (5- FU) plus leucovorin, which helped only ... Oncology Nursing News Yield: Yields intressebolag Isofol kapitaliserat - Dec 16, 2009 Tillsammans har man utvecklat en stabil form av den aktiva metaboliten i LV (Leucovorin) med varumärkesnamnet Modufolin® som tagits fram för att ersätta ... MyNewsdesk (pressmeddelande) UPDATE 1-Spectrum says CMS OKs reimbursement of its cancer drug - Nov 3, 2009 ..."We continue to believe that the FDA will likely ask for an additional clinical trial to show non-inferiority of Fusilev over generic leucovorin," Kappor ... Reuters Merck Eprova and Isofol Medical Enter Exclusive Agreement for Merck Eprova's ... - Nov 11, 2009 Merck Eprova AG will be providing Modufolin®, the active metabolite of LV (Leucovorin), for use in clinical trials and commercial drug products. ... Life Science Leader Magazine Merck Eprova signs license agreement with Isofol Medical for Modufolin(R) - Nov 12, 2009 Under the terms of the agreement, Merck Eprova will provide Modufolin(R), the active metabolite of LV (Leucovorin), for use in clinical trials and ... Trading Markets (press release) Poniard Pharmaceuticals to Present Updated Clinical Data from Phase 2 Trial of ... - Nov 10, 2009 Randomized Phase 2 study of Picoplatin in Combination with 5-fluorouracil and Leucovorin (FOLPI) as a Neuropathy-Sparing Alternative to mFOLFOX-6 as ... CNNMoney.com (press release) 5 Top Stocks at Half Price - Oct 19, 2009 ...the Food and Drug Administration sent a letter to Spectrum saying that Fusilev's data did not confirm the drug's "non-inferiority" to leucovorin. ... Motley Fool Regeneron Reports Third Quarter 2009 Financial and Operating Results - Nov 3, 2009 ...a Phase 2 study (AFFIRM) is being conducted of aflibercept in 1st line metastatic colorectal cancer in combination with folinic acid (leucovorin), ... Reuters Amgen: Vectibix disappoints in colorectal cancer but hope remains - Nov 6, 2009 ...and in the separate Phase III '181' trial, progression-free survival was improved when Vectibix was combined with FOLFIRI (leucovorin, 5-fluorouracil, ... Trading Markets (press release) Comparing notes: UK's cancer leaders discuss the latest advances - Oct 28, 2009 ...with mFOLFOX6 (5-fluorouracil, leucovorin and oxaliplatin) with or without the angiogenesis inhibitor bevacizumab, which was given for 12 months. ... Pharmafocus Spectrum Pharmaceuticals Announces Third Quarter 2009 Corporate Update ... - Nov 12, 2009 FUSILEV (levoleucovorin or (6S)-leucovorin) is the only commercially available formulation containing only the pharmacologically active isomer of leucovorin ... dBusinessNews Los Angeles (press release) Clinical benefits and costs of new treatments for advanced colorectal cancer - Nov 4, 2009 Despite biomodulation with leucovorin, response rates were modest and survival remained approximately 1 year. However, recent advances in translational ... American Journal of Hemotology and Oncology WarraPharm to commercialise colorectal cancer therapy - Nov 8, 2009 As well as combining two of the most commonly prescribed anti-cancer agents (5-fluorouracil and leucovorin), the lead reformulation Fluorodex highlights the ... NewsMaker (press release) Pueden volver a las "quimio" - Nov 3, 2009 ...confirmó que el viernes varios pacientes le comunicaron la situación y después de investigar confirmó la falta de gencitabina, docitaxel y leucovorin. ... Día a día Wachstum dauert an – Aussichten sind gut - Nov 9, 2009 Diese Produkte heissen Metafolin Leucovorin oder Levoleucovorin und werden von der Schaffhauser Firma Merck Eprova hergestellt. Merck Eprova produziert mehr ... Schaffhauser Nachrichten … with irinotecan, 5-fluorouracil and leucovorin for taxane- and... - Jan 26, 2005 They received irinotecan (150 mg m -2 , day 1) and leucovorin (100 mg m -2 , day 1), ... The combination of irinotecan, 5-FU and leucovorin showed moderate ... Nature.com Cancer Doctors Fear Chemo Drug Shortage - Dec 16, 2008 Leucovorin, a modified B vitamin, has been a key ingredient in ... A drug cocktail of 5FU and leucovorin is now a backbone of colon cancer chemotherapy. ... Forbes Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI):... - Apr 30, 2007 This phase II trial was performed to evaluate the efficacy and tolerability of oral tegafur–uracil (UFT ® ) with leucovorin (LV) combined with intravenous ... Nature.com … of oral uracil/ftorafur (UFT ® ) plus leucovorin combined with... - Aug 17, 2005 This phase II trial was performed to evaluate the efficacy and tolerability of a new combination of Uracil/Ftorafur (UFT ® )/leucovorin (LV) and oxaliplatin ... Nature.com A phase II study of UFT with leucovorin administered as a twice daily... - Aug 12, 2008 Correspondence: Dr PM Hoff, Centro de Oncologia do Hospital Sirio Libanes, Rua Adma Jafet 91, Sao Paulo 01308-050, Brazil. E-mail: hoffpaulo@yahoo.com ... Nature.com Roche cancer treatment Xeloda reaches primary endpoint in latest... - Dec 11, 2006 ...oxaliplatin -- was as effective in delaying disease progression as the chemotherapy combination FOLFOX-4 (infused 5-FU/leucovorin plus oxaliplatin). ... Forbes Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or … - Jan 23, 2007 10 The following investigators should be considered as co-authors: Carla Rabbi, Az Osp.'C. Poma', Mantova; Giorgio Cruciani, Az USL Lugo di Romagna, (RA); ... Nature.com Phase III study of 5FU, etoposide and leucovorin (FELV) compared to … - Mar 3, 2005 The purpose of this study was to determine whether epirubicin, cisplatin and infused 5FU (ECF) improves overall survival (OS) compared to 5FU, etoposide and ... Nature.com Experts Compare Colon Cancer Treatment Outcomes - Sep 20, 2007 ..."The fluorouracil, leucovorin, irinotecan, plus bevacizumab regimen especially, which has the highest probability to be the best in improving survival ... Washington Post University's cancer drug windfall - Jul 26, 2006 The 6S-Leucovorin drug was created by Strathclyde professors Hamish Wood and Colin Suckling in ... Leucovorin was an established drug made from folic acid, ... Scotsman … combined with weekly bolus 5-fluorouracil and leucovorin an option... - Aug 17, 2007 Kuebler JP (2007) Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer. ... Nature.com Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line... - Mar 13, 2007 Correspondence: Professor B Neri, Department of Oncology, Centre of Experimental and Clinical Oncology, University of Florence, Careggi, V.le Morgagni 85, ... Nature.com Leucovorin (Systemic).(Drug overview) - May 1, 2006 Leucovorin (loo-koe-VOR-in) is used as an antidote to the harmful effects of methotrexate (a cancer medicine) that is given in high doses. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com … Effective Alternative to Fluorouracil/Leucovorin for Colon Cancer - Jun 29, 2005 NEW YORK Jun 29, 2005 (Reuters Health) - Treatment of stage III colon cancer with adjuvant capecitabine is at least as effective as fluorouracil plus ... Cancerpage.com Eloxatin combo delays relapses after liver surgery - Jun 4, 2007 The drug combination, called FOLFOX4, combines Eloxatin with widely used chemotherapy agents 5-fluorouracil (5-FU) and leucovorin and is commonly used to ... Reuters How It Works - Oct 1, 2008 Leucovorin is a derivative of folic acid. Leucovorin works differently depending on whether it is used with methotrexate (MTX) or fluorouracil (5-FU). ... WebMD Adventrx Sinks as Study Fails - Oct 1, 2007 ...administer ANX-510, also known as CoFactor, plus 5-fluorouracil and compare those results with a combination of leucovorin and 5-fluorouracil. ... TheStreet.com - TheStreet.com (subscription) Duration of adjuvant therapy for colorectal cancer: are we overtreatin... - Feb 19, 2005 This study showed that 6 months of 5-FU/leucovorin adjuvant therapy led to an ... 4 For 5-FU biomodulation, the addition of both levamisole and leucovorin ... Nature.com Learn about Leucovorin from Consumer Reports Health. - Jan 7, 2008 Leucovorin is used to prevent harmful effects of methotrexate (Rheumatrex, Trexall; cancer chemotherapy medication) when methotrexate is used to to treat ... consumerreports.org Preliminary 2006 Protherics PLC Earnings Conference Call - Part 2. - Jun 7, 2006 ANDREW HEATH: Well, I don't think Leucovorin is valid as a comparer ... Leucovorin protects, to some extent, these patients against the negative effects of ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com … Cancer; Epirubicin, cisplatin, UFT, and leucovorin used to treat … - Mar 14, 2006 Oral UFT 400-600 mg/day, determined by body surface area, and leucovorin 75 mg/day were administered for 21 consecutive days, followed by a 7-day drug free ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Colon Cancer Medications - Colon Cancer Health Information - NY Times... - Dec 1, 2008 Leucovorin, also called folinic acid, is a form of the B vitamin folic acid, which helps increase 5-FU's effectiveness. Patients are given a series of ... New York Times Options updated for adjuvant colon cancer Tx.(Clinical Rounds) - May 15, 2005 The oxaliplatin recommendation is based on findings from the Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant ... Free with registration - Family Practice News - AccessMyLibrary.com ADVENTRX Completes Enrollment in CoFactor Phase IIb Metastatic … - Sep 25, 2006 In comparison to leucovorin, CoFactor creates more stable binding of the active ... CoFactor bypasses the chemical pathway required by leucovorin to deliver ... Free with registration - PR Newswire - AccessMyLibrary.com Experts compare colon cancer treatment outcomes - Sep 22, 2007 ...""The fluorouracil, leucovorin, irinotecan, plus bevacizumab regimen especially, which has the highest probability to be the best in improving survival ... Tehran Times FDA Approves New Drug Application (NDA) for LEVOleucovorin, … - Mar 7, 2008 LEVOleucovorin is the only commercially available formulation comprised only of the pharmacologically active enantiomer of leucovorin (Levoleucovorin or ... Free with registration - Business Wire - AccessMyLibrary.com Leucovorin Calcium Injection USP - Jul 12, 2007 Leucovorin is used to reduce toxicity following high-dose methotrexate therapy in a process known as folinic acid rescue. It can also be used in accidental ... Virtual Medical Centre - The Virtual Medical Centre Irinotecan May Improve 5-Fluorouracil/Leucovorin Combination in Stage... - May 18, 2005 May 18, 2005 (Orlando) — Adding irinotecan (Camptosar) to the standard chemotherapy combination of 5-fluorouracil and leucovorin may increase disease-free ... Medscape ADVENTRX Announces Positive CoFactor Phase II Clinical Trial Results ... - Jun 5, 2006 In comparison to leucovorin, CoFactor creates more stable binding of the active ... CoFactor bypasses the chemical pathway required by leucovorin to deliver ... RedOrbit ADVENTRX Presents Positive Data Regarding CoFactor Combination in … - Sep 18, 2006 Median survival time of the UFT-plus-leucovorin group (54 days) and UFT alone ... Animals were treated with identical doses of CoFactor or leucovorin (0.6 ... Free with registration - PR Newswire - AccessMyLibrary.com Patient Treatment Initiated in ADVENTRX International Phase IIb … - May 31, 2005 In comparison to leucovorin, CoFactor creates more stable binding of the active ... CoFactor bypasses the chemical pathway required by leucovorin to deliver ... RedOrbit Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results ... - May 6, 2008 Picoplatin was shown to have manageable toxicity in combination with 5-fluorouracil and leucovorin. Picoplatin did not cause severe neurotoxicity (Grade 3 ... RedOrbit Adventrx Moves Into Phase III With CoFactor, Pulls Offering - May 23, 2006 Designed to enhance 5-FU's ability to inhibit cancer growth, CoFactor is the active metabolite of the generically available leucovorin, but, ... BioWorld Online - BioWorld Online Leucovorin Calcium Preservative Free - Mar 9, 2007 By Luitpold Pharmaceuticals. Leucovorin is a medication that acts the same way in the body as folic acid. Leucovorin is used to reduce the ... MyFox Wausau ADVENTRX PHARMACEUTICALS INC at BIO CEO & Investor … - Feb 12, 2008 CoFactor we're developing is a replacement for generic leucovorin. ... So generic leucovorin is the preferred method to enhance the activity and reduce the ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com ADVENTRX Announces 2005 First Quarter Financial Results. - May 13, 2005 In comparison to leucovorin, CoFactor creates more stable binding of the active ... CoFactor bypasses the chemical pathway required by leucovorin to deliver ... $4.95 - Business Wire - ECNext Leucovorin Calcium Preservative Free - Mar 9, 2007 By Luitpold Pharmaceuticals. A side effect is an unwanted response to a medication when it is taken in normal doses. A side effect may be mild or severe, ... MyFox Wausau ASCO: Oxaliplatin (Eloxatin) Gives Survival Edge for Colon Cancer - Jun 1, 2008 Together with fluorouracil (Adrucil) and leucovorin (Wellcovorin), oxaliplatin improved the relative odds of disease-free survival by 19% at five years, ... MedPage Today NCCN: New Guidelines Update Adjuvant Colon Cancer Treatment - Mar 21, 2005 M0 colon cancer, clinicians should provide 5-FU/leucovorin or Xeloda ... For T4, N1-2, M0 disease, the choices expand to include 5-FU/leucovorin in ... MedPage Today … treated by 5-fluoruracil, leucovorin, epirubicin and carbopl - Sep 5, 2006 ..."5-fluoruracil 750 mg/sqm, leucovorin 75 mg/sqm, epirubicin 45 mg/sqm, carboplatin 225 mg/sqm were administered every 3 weeks into celiac axis for 3 cycles ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Updated Phase II COFU Trial Data - Jun 20, 2005 In comparison to leucovorin, CoFactor creates more stable binding of the active ... CoFactor bypasses the chemical pathway required by leucovorin to deliver ... RxPG NEWS … With Capecitabine After 5-Fluorouracil/ Leucovorin in Adjuvant... - Jul 10, 2007 ...[Presentation title: Unexpected Sequence-Specific Toxicity of Capecitabine Following 5-Fluorouracil/ Leucovorin When Used in the Adjuvant Treatment of ... DG News Perioperative Eloxatin Regimen Reduced Risk Of Relapse In Colorectal ... - Mar 24, 2008 EORTC 40983 Intergroup study showed that in eligible patients Eloxatin (oxaliplatin injection) in combination with 5-fluorouracil/leucovorin (5-FU/LV), ... emaxhealth.com Pro-Pharmaceuticals Updates Clinical Trials Progress. - Aug 30, 2006 US-based Phase II, line one clinical trial of DAVANAT(R) with Avastin(R), 5-FU and leucovorin for patients with locally advanced and unresectable or ... Free with registration - Business Wire - AccessMyLibrary.com Gentler Oral Chemotherapy Shows Efficacy in Advanced Colon Cancer - Jun 29, 2005 ...of Eloxatin (oxaliplatin) with intravenous fluorouracil and leucovorin as optimal adjuvant therapy when multiagent adjuvant regimens are used. ... MedPage Today Pro-Pharmaceuticals presents Phase II/III clinical trials at the... - Feb 24, 2006 The full trial is expected to have up to 800 patients in 60 centres and consist of four arms: Irinotecan, leucovorin and 5-FU (Folfiri) with and without ... Pay-Per-View - Company Reports - Factiva, from Dow Jones Poniard Pharmaceuticals Announces Picoplatin Safety Data In Colorectal... - Jan 28, 2008 The poster presentation included safety data from a Phase 1 study of picoplatin in combination with 5-fluorouracil (5FU) and leucovorin (LV) as a first-line ... Medical News Today - Medical News Today (press release) ADVENTRX Presents Enhanced Antitumor Activity and Lower Systemic … - Apr 19, 2005 ..."As such, CoFactor might be a valuable replacement for leucovorin in combination regimens ... CoFactor creates more stable binding, compared to leucovorin, ... RedOrbit SCOUT Regimen Useful as First-Line Treatment for Metastatic Colorectal... - Sep 26, 2007 The maximum tolerated dose was established at UFT 250 mg/m 2 /day, leucovorin 90 mg/day, irinotecan 180 mg/m 2 , and oxaliplatin 100 mg/m 2 . ... DG News Addition of Oxaliplatin to FOLFIRI Regimen Increases Survival of... - Jan 30, 2006 Doctors in the Gruppo Oncologico Nord Ovest in Italy said that by adding oxaliplatin to FOLFIRI (5-fluorouracil and leucovorin with irinotecan) -- creating ... DG News Breast Cancer; Toxicity of UFT and leucovorin higher in older women... - Apr 5, 2005 2005 APR 5 - (NewsRx.com) -- Results of a Phase II clinical trial showed that ftorafur plus uracil treatment (UFT) and leucovorin produced increased ... Pay-Per-View - Cancer Weekly - Factiva, from Dow Jones Dabur Pharma Launches Irinotecan Hydrochloride Injection in United … - Feb 28, 2008 Irinotecan is indicated as a component of first line therapy in combination with 5- fluorouracil and leucovorin for patients with metastatic carcinoma of ... Equity Bulls ADVENTRX Announces Fast Track Designation Granted By The FDA For … - Aug 17, 2007 In comparison to leucovorin, CoFactor creates more stable binding of the active form ... CoFactor bypasses the metabolic pathway required by leucovorin to ... Medical News Today - Medical News Today (press release) Irinotecan or Oxaliplatin Combined with Leucovorin and 5-Fluorouracil - Jul 1, 2005 Stuart M. Lichtman, MD, FACP, Associate Attending, Memorial Sloan-Kettering Cancer Center, Commack, New York, is on the Editorial board for Clinical ... Pay-Per-View - Clinical Oncology Report - Factiva, from Dow Jones Pro-Pharmaceuticals Announces Dosing of Patients with DAVANAT(R) in … - Nov 27, 2006 The Phase II trial is an open-label, multi-center trial of DAVANAT([R]) with Avastin([R]), 5-Fluorouracil (5-FU) and Leucovorin in patients with locally ... Free with registration - Business Wire - AccessMyLibrary.com milk daily i untuned with vitamin tint not always correct - Nov 27, 2007 I also take prednisone, gabapentin, methotrexate and leucovorin. Could one of these drugs interfere with vitamin D absorption? ... Lakeland Ledger - Google News Archive Colon Cancer; Irinotecan, leucovorin, 5-fluorouracil and tegafur/uraci... - Sep 13, 2005 2005 SEP 13 - (NewsRx.com) -- Scientists conducted a phase II study of irinotecan, leucovorin, 5-fluorouracil (5FU) and tegafur/uracil (UFT) for metastatic ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones ADVENTRX Provides Update on Cofactor(R) Program - Nov 2, 2007 Compared to leucovorin, CoFactor creates more stable binding of the active ... CoFactor bypasses the metabolic pathway required by leucovorin to deliver the ... Genetic Engineering News - Genetic Engineering News (press release) Trimetrexate (Systemic). - Oct 27, 2005 Trimetrexate (tri-me-TREX-ate) is used, together with leucovorin (loo-koe-VOR-in ... To prevent these effects, (you must take another medicine, leucovorin, ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Colon Cancer; Recent findings from Denmark, Greece and the United … - May 10, 2006 The preexisting treatment of leucovorin-5-fluorouracil-irinotecan (IFL), although reasonably effective, has needed novel, active agents to increase the ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Chemotherapy; Etoposide, leucovorin, and 5-fluorouracil used to treat... - Nov 22, 2005 2005 NOV 22 - (NewsRx.com) -- Etoposide, leucovorin and 5-fluorouracil (ELF) could be used to treat resected gastric cancer. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones FDA Extends ISO-Vorin(TM) Action Date by Sixty Days. - Nov 20, 2007 ISO-Vorin[TM] is the pure active isomer of calcium leucovorin. Calcium leucovorin is used after the administration of high-dose methotrexate in treating ... Free with registration - Business Wire - AccessMyLibrary.com … Addition of Oxaliplatin to 5-FU Plus Leucovorin Improves Disease... - May 14, 2005 Researchers Announce Addition of Oxaliplatin to 5-FU Plus Leucovorin Improves Disease-Free Survival in Patients with Stage II and Stage III Colon Cancer. Pay-Per-View - PR Newswire - HighBeam Research Illinois Administrative Code - 77 Ill. Adm. Code 790.5544 LEUCOVORIN ... - Aug 10, 2005 77 Ill. Adm. Code 790.5544 LEUCOVORIN CALCIUM (Repealed) Repealed. (Source: Repealed at 17 Ill. Reg. 15916, effective September 20, 1993) ... Pay-Per-View - Illinois Administrative Code - Loislaw Press Release: ADVENTRX Announces Preliminary Response Rate Data … - Jul 1, 2008 Eighty-nine patients were randomized to either the leucovorin control arm or the ... Events (version 3)) in the CoFactor/5-FU arm over the leucovorin/5 ... ... Pay-Per-View - PR Newswire - HighBeam Research Patient dosing begins in Ph II Davanat trial.(Brief article) - Dec 22, 2006 5-fluorouracil and leucovorin in those with locally-advanced, unresectable or metastatic colorectal cancer, unable to tolerate chemotherapy. ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Protherics PLC - Product Update. - Jan 11, 2007 In addition, the EMEA has requested further work assessing the potential of Voraxaze(TM) to interact with leucovorin, which is currently administered in ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com Article: Capecitabine for stage III colon ca.(CLINICAL CAPSULES)(colon... - Aug 15, 2005 UFT (uracil and tegafur) capsules plus leucovorin calcium tablets be ... 500 mg/m2 iv bolus weekly x 6, plus leucovorin 500 mg/m2 iv weekly x 6, each 8 ... ... Pay-Per-View - Internal Medicine News - HighBeam Research What is the standard chemotherapy for colorectal cancer patients with... - Jun 30, 2008 8 By contrast the FFCD study using 5-FU and leucovorin had a positive outcome ... Does this finding mean a study of FOLFOX4 versus 5-FU/leucovorin should be ... Nature.com Chronopharmacokinetics of Oral Tegafur and Uracil in Colorectal... - Mar 23, 2007 UFT is an effective alternative to intravenous FU-Leucovorin (LV) in metastatic ... Multicenter phase III study of uracil/tegafur and oral leucovorin versus ... Nature.com Press Release: ADVENTRX Announces Positive Data From Multidrug … - Apr 18, 2007 In comparison to leucovorin, CoFactor creates more stable binding of the active form ... CoFactor bypasses the metabolic pathway required by leucovorin to ... Pay-Per-View - PR Newswire - HighBeam Research ADVENTRX Announces Preliminary Response Rate Data From … - Jul 1, 2008 Eighty-nine patients were randomized to either the leucovorin control arm or ... CoFactor is a folate-based biomodulator designed to replace leucovorin as ... RedOrbit [U] Ehlschide v. Colonial Life & Accident Insurance Co., No. 2004-CA-... - Aug 19, 2005 Leucovorin is not itself a cancer destroying agent, but it prolongs the ... Nevertheless, the company maintained that because Leucovorin is not a cancercide ... $2.95 - Kentucky Court of Appeals - VersusLaw ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall … - Jun 16, 2008 CoFactor is a folate-based biomodulator designed to replace leucovorin as the ... Compared to leucovorin, CoFactor creates more stable binding between the ... RedOrbit Poniard Pharmaceuticals Announces Promising Data From Interim Safety ... - Jun 2, 2007 Initial safety data from the Phase 1 trial in CRC demonstrated that picoplatin can be safely administered with fluorouracil and leucovorin, and initial ... Medical News Today - Medical News Today (press release) Substituting Oral Capecitabine in Colorectal Cancer "Not Convincing" - Sep 3, 2007 One of the trials, conducted in Germany and headed by Rainer Porschen, MD, from Hospital Bremen East, compared this with a regimen of FU with leucovorin and ... Medscape Press Release: ADVENTRX Presents Positive Data Regarding CoFactor … - Sep 18, 2006 Median survival time of the UFT-plus-leucovorin group (54 days) and UFT alone ... Animals were treated with identical doses of CoFactor or leucovorin (0.6 ... Pay-Per-View - PR Newswire - HighBeam Research With backing of a big-time investor, SD biotech eyes advancing cancer... - Aug 19, 2005 CoFactor is a derivative of the generic drug leucovorin, ... The aim of CoFactor and leucovorin is to enhance 5-FU's inhibition of a key enzyme that is ... Free with registration - San Diego Union - Tribune - AccessMyLibrary.com Poniard Announces Positive Preliminary Efficacy and Safety Data From ... - Jun 1, 2008 Preliminary data suggest that picoplatin given in combination with 5-fluorouracil and leucovorin (FOLPI) and oxaliplatin given in combination with ... RedOrbit New Drug Application Filing for Levoleucovorin Tablets Completed By … - Jun 5, 2008 Concomitant use of d,l-leucovorin with trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia in HIV patients was associated with increased rates ... RedOrbit Spectrum Pharmaceuticals Announces FUSILEV(TM) as Tradename for … - Jun 17, 2008 Concomitant use of d,l-leucovorin with trimethoprim-sulfamethoxazole for pneumocystis carinii pneumonia in HIV patients was associated with increased rates ... Genetic Engineering News - Genetic Engineering News (press release) Q3 2007 Spectrum Pharmaceuticals Inc Earnings Conference Call - Final. - Nov 9, 2007 IMS data shows that it generates nearly $200 million in annual sales, in spite of the availability of generic forms of racemic leucovorin in both of those ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com … Drug Designations Relating to Isovorin -L-Leucovorin- for Colon C - Mar 2, 2005 L-leucovorin is the 'active' isomer of the racemic leucovorin widely used today in many regimens containing 5-Fluorouracil in the treatment of a variety of ... Free with registration - Business Wire - AccessMyLibrary.com Colorectal Cancer; Adventrx completes enrollment in CoFactor phase... - Oct 24, 2006 In comparison to leucovorin, CoFactor creates more stable binding of the active ... CoFactor bypasses the chemical pathway required by leucovorin to deliver ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Colon Cancer; Studies advance knowledge in colon cancer research - Mar 28, 2006 Study 2: Scientists conducted a phase II study of irinotecan, leucovorin, ... Adverse events consistent with those expected from FU/leucovorin-or IFL-based ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Press Release: ADVENTRX Announces CoFactor(R) Phase 2b Clinical … - Jun 16, 2008 CoFactor is a folate-based biomodulator designed to replace leucovorin as the ... Compared to leucovorin, CoFactor creates more stable binding between the ... Pay-Per-View - PR Newswire - HighBeam Research Treatment of metastatic urachal carcinoma in an elderly woman - Apr 13, 2007 6 A phase II trial with 5-FU, leucovorin, cisplatin, and gemcitabine for ... 13 Currently, irinotecan in combination with 5-FU/leucovorin with or without ... Nature.com Article: Options updated for adjuvant colon cancer Tx.(Gastroenterolog... - May 1, 2005 Article: Trimetrexate and leucovorin modulate 5-FU in advanced ... Gastroenterology Week; June 14, 2004 ; 700+ words ... ... Trimetrexate and leucovorin ... Pay-Per-View - Internal Medicine News - HighBeam Research Article: Options updated for adjuvant colon cancer Tx.(Clinical... - May 15, 2005 Article: Trimetrexate and leucovorin modulate 5-FU in advanced ... Gastroenterology Week; June 14, 2004 ; 700+ words ... ... Trimetrexate and leucovorin ... Pay-Per-View - Family Practice News - HighBeam Research Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of... - Aug 9, 2006 The feasibility of combining UFT plus leucovorin (LV) with alternating irinotecan and oxaliplatin was investigated in the first-line treatment of patients ... Nature.com Cancer - Spectrum Pharmaceuticals Launches FUSILEV For Injection - Aug 18, 2008 ..."We believe the market potential of FUSILEV, as a replacement for leucovorin, could be significant. In the US, there are more than 500 million milligrams of ... Medical News Today - Medical News Today (press release) Spectrum Pharmaceuticals Files Supplemental New Drug Application … - Oct 31, 2008 ..."Ninety percent of the more than 500 million milligrams of leucovorin used in the United States is for colorectal cancer," said Rajesh C. Shrotriya, MD, ... International Business Times Spectrum Pharmaceuticals Launches FUSILEV(TM) - Aug 15, 2008 ..."We believe the market potential of FUSILEV, as a replacement for leucovorin, could be significant. In the US, there are more than 500 million milligrams of ... Genetic Engineering News - Genetic Engineering News (press release) A prospective randomised trial to study the role of levamisole and … - Apr 26, 2005 The NSABP trial C-04 compared the efficacy of 5-FU plus leucovorin with 5-FU plus ... The comparison between patients treated with 5-FU plus leucovorin and ... Nature.com The clinical and economic benefits of capecitabine and tegafur with... - Jun 15, 2005 One is a 5-fluorouracil pro-drug, capecitabine; the other is a combination of tegafur and uracil administered together with leucovorin. ... Nature.com … phase III trial of adjuvant chemotherapy with 5-fluorouracil and... - May 9, 2007 The Multicenter International Study of Oxaliplatin/5-FU/ Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) compared the efficacy of adjuvant ... Nature.com Is bevacizumab effective and safe in combination with chemotherapy in... - Dec 13, 2006 ...(2006) A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal ... Nature.com … vs. monatlicher Fluorouracil/Leucovorin-Gabe als adjuvante Therapi - Oct 8, 2007 C96.1-Studie hat eine internationale Arbeitsgruppe um Thierry André die halbmonatliche Gabe von Fluorouracil und Leucovorin (LV5FU2) mit der monatlichen ... Internetportal der Deutschen Krebsgesell... Cancer Research; Pharmaceutical company reports transfer of orphan … - Mar 28, 2005 L-leucovorin is the 'active' isomer of the racemic leucovorin widely used today in many regimens containing 5-Fluorouracil in the treatment of a variety of ... Pay-Per-View - Biotech Business Week - Factiva, from Dow Jones Cancer Research; Pharmaceutical company reports transfer of orphan … - Mar 29, 2005 L-leucovorin is the 'active' isomer of the racemic leucovorin widely used today in many regimens containing 5-Fluorouracil in the treatment of a variety of ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Brand Names/Synonyms: Leucovorin is also known by the following brand names and/or synonymsAcide Folinique; C03479; Calcium Citrovorum Factor; Calcium Folinate; Citrovorum Factor; Folinic Acid; Folinic Acid Calcium Salt; Folinic Acid-Sf; Folinic Acid-Sf, Calcium Salt; Folinic Acidcalcium Salt Usp27; L-Leucovorin; Leucal; Leucovorin Calcium; Leucovorin Calcium Preservative Free; Leucovorin Folinic Acid; Leucovorin [Usan]; Wellcovorin Drug Category: Leucovorin is categorized under the following by the FDA: Hematinics; Antihypertensive Agents; Methotrexate Antidote; Unclassified Therapeutic Agents (92:00.00); Dosage Forms: LIQUID; POWDER FOR SOLUTION; SOLUTION; TABLET Absorption: Following oral administration, leucovorin is rapidly absorbed. The apparent bioavailability of leucovorin was 97% for 25 mg, 75% for 50 mg, and 37% for 100 mg. Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 2-[4-[(2-amino-5-formyl-4-oxo-5,6,7,8-tetrahydro-1H-pteridin-6-yl)methylamino]benzoyl]aminopentanedioicacid |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |